Thurston Springer Miller Herd & Titak’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Buy
5,128
+577
+13% +$50.5K 0.17% 147
2026
Q1
$388K Sell
4,551
-875
-16% -$78K 0.16% 163
2025
Q4
$429K Buy
5,426
+3,301
+155% +$259K 0.15% 164
2025
Q3
$170K Sell
2,125
-31,910
-94% -$2.72M 0.34% 94
2025
Q2
$3.09M Buy
34,035
+5,016
+17% +$458K 0.4% 66
2025
Q1
$2.72M Buy
29,019
+5,343
+23% +$478K 0.46% 58
2024
Q4
$2.15M Buy
23,676
+9,682
+69% +$924K 0.44% 55
2024
Q3
$1.45M Buy
13,994
+763
+6% +$77.8K 0.4% 62
2024
Q2
$1.28M Buy
+13,231
New +$1.22M 0.4% 63

Other funds holding CL

Thurston Springer Miller Herd & Titak's CL Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Colgate-Palmolive (CL) stake by 13% in Q2 2026, buying an estimated $50.5K and bringing the position to 5,128 shares worth $470K. The position accounts for 0.17% of the portfolio, ranked #147.

Thurston Springer Miller Herd & Titak first reported a position in CL in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.09M in Q2 2025. 647 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 5,128 shares of Colgate-Palmolive worth $470K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 577 Colgate-Palmolive shares in Q2 2026, an estimated $50.5K.
  • Colgate-Palmolive made up 0.17% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #147 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 9 quarters since.
  • Thurston Springer Miller Herd & Titak's Colgate-Palmolive position peaked at $3.09M in Q2 2025.
  • 647 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.